Mersana Therapeutics Inc (MRSN)
2.94
+0.09
(+3.16%)
USD |
NASDAQ |
Apr 26, 16:00
2.925
-0.02
(-0.51%)
After-Hours: 20:00
Mersana Therapeutics Debt to Equity Ratio: 0.6837 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.6837 |
| September 30, 2023 | 0.4819 |
| June 30, 2023 | 0.2793 |
| March 31, 2023 | 0.3889 |
| December 31, 2022 | 0.2708 |
| September 30, 2022 | 0.2754 |
| June 30, 2022 | 0.1849 |
| March 31, 2022 | 0.1758 |
| December 31, 2021 | 0.2023 |
| September 30, 2021 | 0.0326 |
| June 30, 2021 | 0.0258 |
| March 31, 2021 | 0.0253 |
| December 31, 2020 | 0.0218 |
| September 30, 2020 | 0.0195 |
| June 30, 2020 | 0.018 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0776 |
| December 31, 2019 | 0.0622 |
| September 30, 2019 | 0.052 |
| June 30, 2019 | 0.0443 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.018
Minimum
Jun 2020
0.6837
Maximum
Dec 2023
0.1748
Average
0.0776
Median
Mar 2020
Debt to Equity Ratio Benchmarks
| Amicus Therapeutics Inc | 2.422 |
| Geron Corp | 0.3305 |
| TG Therapeutics Inc | 0.6238 |
| Editas Medicine Inc | 0.00 |
| G1 Therapeutics Inc | 1.457 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 226.06M |
| Total Liabilities (Quarterly) | 189.16M |
| Shareholders Equity (Quarterly) | 36.90M |
| Current Ratio | 3.364 |
| Net Debt Paydown Yield | -0.03% |